QUIA PHARMA AB (STU:99B0) Volatility: 152.10% (As of Jun. 27, 2026)


STU:99B0 QUIA PHARMA AB STU:99B0
4 GF Score
Price €0.00
! 3 Warning Signs
View Full Analysis

What is QUIA PHARMA AB Volatility?

QUIA PHARMA AB STU:99B0 4 Volatility is 152.10% as of Jun. 27, 2026. GuruFocus rates STU:99B0 with a GF Score™ of 4/100. The stock has 3 warning signs investors should review.

Volatility is a statistical measure of the dispersion of returns for a given security or market index, it shows how the price swings around its mean. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year. In most cases, the higher the volatility, the riskier the security.

As of today (2026-06-27), QUIA PHARMA AB's Volatility is 152.10%.

QUIA PHARMA AB  (STU:99B0) Volatility Explanation

Volatility is a statistical measure of the dispersion of returns for a given security or market index. It’s often measured as standard deviation or variance of historical returns over a certain period. The volatility here is measured as the annualized standard deviation between monthly returns from the security over the past year.

Volatility reflects the uncertainty or risk of a security’s value. Generally speaking, a higher volatility suggests a higher risk, because it implies a wider fluctuation around average price. This means the price of the security can change dramatically in either direction within a short period. Conversely, a lower volatility means that the security's price is more steady, which suggests a lower risk.

Another measurement of relative volatility is Beta. Beta is a measure of systematic risk of a security or a portfolio in comparison to the market as a whole. Beta is usually compared to 1. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

QUIA PHARMA AB Volatility Related Terms

STU:99B0 vs VRTX, REGN, ALNY: Volatility Comparison

For the Biotechnology subindustry, QUIA PHARMA AB's Volatility, along with its competitors' market caps and Volatility data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

QUIA PHARMA AB Volatility vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, QUIA PHARMA AB's Volatility distribution charts can be found below:

* The bar in red indicates where QUIA PHARMA AB's Volatility falls into.


STU:99B0
4GF Score
QUIA PHARMA AB STU:99B0
Volatility is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

QUIA PHARMA AB  (STU:99B0) Volatility Calculation

The annualized volatility is calculated as following:

σA=σM * √12
=√ 1/(n-1) ∑(Ri - R')^2 * √12

Where: σM is the monthly volatility, n is the number of months in the period, Ri is the security's historical monthly returns and R' is the arithmetic mean of monthly returns.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Volatility →
What does a Volatility of 152.10% mean?
QUIA PHARMA AB (STU:99B0) has a Volatility of 152.10% as of Jun. 27, 2026. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on QUIA PHARMA AB and its competitors.
Is QUIA PHARMA AB's Volatility too high?
QUIA PHARMA AB's current Volatility is 152.10%. Overall, QUIA PHARMA AB has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does QUIA PHARMA AB's Volatility compare to VRTX and REGN?
QUIA PHARMA AB's Volatility of 152.10% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Volatility for a Biotechnology company?
A good Volatility depends on the Biotechnology industry context. However, Volatility should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Volatility mean?
A high Volatility can signal that a stock is expensive relative to its fundamentals. Volatility is measured as the annualized standard deviation between monthly returns from the security over the past year. View historical data on QUIA PHARMA AB and its competitors. QUIA PHARMA AB's current Volatility is 152.10%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is QUIA PHARMA AB stock overvalued right now?
QUIA PHARMA AB (STU:99B0) has a current Volatility of 152.10%. The current Volatility is 152.10%. QUIA PHARMA AB's overall GF Score™ is 4/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Volatility calculated?
Volatility is calculated from a company's financial statements. For QUIA PHARMA AB (STU:99B0), the current Volatility is 152.10% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

QUIA PHARMA AB Business Description

Address Virdings Alle 32 B, Uppsala, SWE, 754 50
QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.
4GF Score

Get the complete analysis for STU:99B0

Volatility is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.00
Price